Clinical Trial Update: Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study evaluated potential drug interactions between Farxiga (dapagliflozin) and Amaryl (glimepiride) in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Amaryl (glimepiride)
• FARXIGA (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED